2025 ASCO Gastrointestinal Cancers Symposium – Conference Preview

Published on

The 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium will be held from Thursday, January 23 to Saturday, January 25, 2025, at Moscone West in San Francisco, CA. This symposium serves as an important platform for staying abreast of the most recent advancements in research and gaining insights from leading experts on the management and treatment of intricate patient cases. Additionally, it presents an invaluable occasion to engage with peers and thought leaders in the field, fostering networking opportunities that can prove beneficial for professional growth and collaboration.

To secure your attendance at this esteemed event, we highly recommend registering promptly by clicking here. By doing so, you will have the chance to secure accommodations, access travel information, plan your itinerary, and guarantee your participation in educational and networking activities before they reach full capacity.

Below, you will find a list of sessions that we are eagerly looking forward to at #GI25. The sessions are organized in chronological order for your convenience.

Intersections: Emerging Therapies in Gastrointestinal Cancers

  • Date/Time: January 23, 2025 7:50 AM – 9:00 AM PST
  • Location: Level 2, Ballroom | Live Stream
  • Discover the latest advancements in therapies targeting new areas, such as bispecifics, ADCs, CAR-T, and radioligand therapy for gastrointestinal cancers. The expert panel will discuss potential obstacles and future outlooks for these innovative treatments.

Patient-Centric Management of Gastric Cancer

  • Date/Time: January 23, 2025, 10:30 AM – 11:30 AM PST
  • Location: Level 2, Ballroom | Live Stream
  • This session will highlight the latest advancements in treating patients with gastric cancer at every stage of the disease. It will cover topics such as screening and endoscopic management for early gastric cancer, recent developments in treating locally advanced gastric cancer, and the use of multidisciplinary approaches for treating metastatic gastric cancer.

Integrating Local With Systemic Therapies for Esophagus and Gastroesophageal Junction Cancers

  • Date/Time: January 23, 2025, 4:00 PM – 5:00 PM PS
  • Location: Level 2, Ballroom | Live Stream
  • Delve into the various local and systemic therapies available for esophageal and gastroesophageal (GE) cancers. Discover the significance of radiotherapy, advancements in targeted systemic treatments, and the effectiveness of endoscopic procedures. Acquire expert knowledge on patient selection, treatment strategies, and the importance of multidisciplinary teamwork in managing these types of cancers.

Intersections: Personalized Risk Assessment for Gastrointestinal Cancers

  • Date/Time: January 24, 2025, 7:55 AM – 9:00 AM PST
  • Location: Level 2, Ballroom | Live Stream
  • Learn about the latest advancements in risk scores and biomarkers for screening and early detection of colorectal, esophageal, and pancreatic cancers. Gain insights into the current research and understanding of the microbiome’s role in colorectal cancer.

Breaking Barriers: A Novel Immunotherapy Approach for Cholangiocarcinoma, Hepatocellular, and Pancreatic Cancers

  • Date/Time: January 24, 2025, 10:30 AM – 11:30 AM PST
  • Location: Level 2, Ballroom | Live Stream
  • Learn about innovative approaches for treating HPB cancer that are on the horizon. Delve into advancements in Antibody Drug Conjugates, vaccines, cellular therapies, bi-specific inhibitors, and novel checkpoint inhibitors. Engage in discussions on key indicators that can accelerate the development of these promising therapies.

To Treat or Not to Treat: Debating Adjuvant Therapy for Resectable Hepatocellular Carcinoma and Exploring Optimal Management Strategies for Intermediate-Stage Hepatocellular Carcinoma

  • Date/Time: January 24, 2025, 3:00 PM – 4:00 PM PST
  • Location: Level 2, Ballroom | Live Stream
  • Discuss the latest data regarding adjuvant systemic therapy for patients with hepatocellular carcinoma following surgical resection. Explore the factors that may impact the decision between locoregional and systemic therapy for patients with intermediate stage HCC.

Intersections: Integrative Oncology—Evidence-Based Approaches for Patients With Gastrointestinal Cancers

  • Date/Time: January 25, 2025, 7:55 AM – 9:00 AM PST
  • Location: Level 2, Ballroom | Live Stream
  • Research the latest data that supports the integration of acupuncture, supplements, mind-body practices, and physical activity into comprehensive cancer care. Enhance your understanding of practical strategies for implementing these evidence-based complementary therapies for patients with gastrointestinal cancers.

The 2025 ASCO GI Cancers Symposium is set to be an enriching and informative event. We recommend clicking here to explore the comprehensive list of topics and sessions that will be covered at this significant event. Don’t miss the opportunity to expand your expertise — register today. See you in San Francisco!

Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our recap post the conference.


Copyright © 2025 Guideline Central, All Rights Reserved.